Medicine & Pharmaceuticals

Latest News Releases

*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

Medicine & Pharmaceuticals News Releases via PRNewswireMore>>
Fibromyalgia Patients May Be Grouped by Symptom and Severity Level, Informing Therapeutic Decisions, Study Finds
Fibromyalgia Patients May Be Grouped by Symptom and Severity Level, Informing Therapeutic Decisions, Study Finds
Examining outcome data on fibromyalgia, researchers were able to fit fibromyalgia patients into 1 of 4 symptom domains, each distinguished by greater presence or severity of specific symptoms. The study results, which...More >>
Examining outcome data on fibromyalgia, researchers were able to fit fibromyalgia patients into 1 of 4 symptom domains, each distinguished by greater presence or severity of specific symptoms. The study results, which...More >>
Prescriptions for Benzodiazepines Rising and Risky When Combined with Opioids, Stanford Researchers Warn
Prescriptions for Benzodiazepines Rising and Risky When Combined with Opioids, Stanford Researchers Warn
Prescriptions for benzodiazepines are rising in primary care, and their frequent combined use with opioid analgesics may be contributing to medication-related deaths, a finding that goes largely unreported, according to...More >>
Prescriptions for benzodiazepines are rising in primary care, and their frequent combined use with opioid analgesics may be contributing to medication-related deaths, a finding that goes largely unreported, according to...More >>
Reducing Wait Times Could Improve Spinal Cord Stimulator Success for Chronic Pain
Reducing Wait Times Could Improve Spinal Cord Stimulator Success for Chronic Pain
Success rates soared to 75% for patients who waited less than 2 years for a spinal cord stimulator (SCS) implant, compared with 15% for patients whose implants happened 20 years after the onset of pain, according to a...More >>
Success rates soared to 75% for patients who waited less than 2 years for a spinal cord stimulator (SCS) implant, compared with 15% for patients whose implants happened 20 years after the onset of pain, according to a...More >>
Half of Veterans Prescribed Medical Opioids Continue to Use Them Chronically, Study Finds
Half of Veterans Prescribed Medical Opioids Continue to Use Them Chronically, Study Finds
Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30th Annual Meeting of...More >>
Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30th Annual Meeting of...More >>
Top Maetrics Executive Outlines Potentially Cataclysmic Risk Exposure For Life Sciences Mobile App And Software Developers At ICSQ
Top Maetrics Executive Outlines Potentially Cataclysmic Risk Exposure For Life Sciences Mobile App And Software Developers At ICSQ
"This is a wake-up call for software companies and mobile app developers who are not used to the rigors, structure, and measured pace of the life sciences compliance world. Most of them will need a helping hand to get...More >>
"This is a wake-up call for software companies and mobile app developers who are not used to the rigors, structure, and measured pace of the life sciences compliance world. Most of them will need a helping hand to get...More >>
Attention Immunomedics, Inc. Investors: Immunomedics Misled Investors According to a Recently Filed Class Action
Attention Immunomedics, Inc. Investors: Immunomedics Misled Investors According to a Recently Filed Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Immunomedics, Inc. (NASDAQ: IMMU) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of New...More >>
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Immunomedics, Inc. (NASDAQ: IMMU) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of New...More >>
Aratana Therapeutics to Present at Two Upcoming Investor Conferences
Aratana Therapeutics to Present at Two Upcoming Investor Conferences
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion...More >>
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing or acquisition, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion...More >>
Clintrax Global Partners With Acorn Applications To Extend Clinical Trial Contracting Solution
Clintrax Global Partners With Acorn Applications To Extend Clinical Trial Contracting Solution
Acorn Applications, LLC, a developer of cloud-based analytic clinical research solutions, announced today that Clintrax Global, a clinical trial contract negotiation company, has selected TrialCTA as its new global...More >>
Acorn Applications, LLC, a developer of cloud-based analytic clinical research solutions, announced today that Clintrax Global, a clinical trial contract negotiation company, has selected TrialCTA as its new global...More >>
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2013 Financial Results
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2013 Financial Results
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter and year ended December 31, 2013.More >>
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter and year ended December 31, 2013.More >>
Vermillion Reports Fourth Quarter and Full Year 2013 Results
Vermillion Reports Fourth Quarter and Full Year 2013 Results
Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for the fourth quarter and full year ended December 31, 2013.More >>
Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, reported on its results for the fourth quarter and full year ended December 31, 2013.More >>
Alexza Reports Fourth Quarter and Year End 2013 Financial Results
Alexza Reports Fourth Quarter and Year End 2013 Financial Results
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter and year ended December 31, 2013. The net loss for the fourth quarter was $5.7 million compared to $10.3 million during the same...More >>
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter and year ended December 31, 2013. The net loss for the fourth quarter was $5.7 million compared to $10.3 million during the same...More >>
LabStyle Innovations, Creator of Dario™ Diabetes mHealth Solution, to present at the 26th Annual Roth Conference on March 11, 2014
LabStyle Innovations, Creator of Dario™ Diabetes mHealth Solution, to present at the 26th Annual Roth Conference on March 11, 2014
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes mHealth Solution, today announced that its president and chief executive officer, Mr. Erez Rafael, will be presenting at the 26th Annual Roth...More >>
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes mHealth Solution, today announced that its president and chief executive officer, Mr. Erez Rafael, will be presenting at the 26th Annual Roth...More >>
PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
PTC Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported its financial results for the fourth quarter and full-year ended December 31, 2013.More >>
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported its financial results for the fourth quarter and full-year ended December 31, 2013.More >>
ulrich medical USA® Enters U.S. Tourniquet Market
ulrich medical USA® Enters U.S. Tourniquet Market
ulrich medical USA, Inc., announced today the creation of a new U.S. hospital devices business unit with the release of innovative, high-tech pneumatic tourniquet devices. ulrich medical Inc., the German parent company of...More >>
ulrich medical USA, Inc., announced today the creation of a new U.S. hospital devices business unit with the release of innovative, high-tech pneumatic tourniquet devices. ulrich medical Inc., the German parent company of...More >>
McCord Research to Introduce New Viniferamine® Skin Care System, Developed by Dr. Darlene McCord, at the Peak Leadership Summit Expo
McCord Research to Introduce New Viniferamine® Skin Care System, Developed by Dr. Darlene McCord, at the Peak Leadership Summit Expo
McCord Research will be exhibiting at the 2014 Peak Leadership Summit Expo held in Washington, DC. The expo will be on Monday, March 17th, at the Washington Marriott Wardman Park Hotel. McCord Research was founded by...More >>
McCord Research will be exhibiting at the 2014 Peak Leadership Summit Expo held in Washington, DC. The expo will be on Monday, March 17th, at the Washington Marriott Wardman Park Hotel. McCord Research was founded by...More >>
Misonix Exhibits At The 65th Southern Neurosurgical Society Annual Conference And Offers Extensive "Hands-On" BoneScalpel™ and SonaStar® Product Demonstrations
Misonix Exhibits At The 65th Southern Neurosurgical Society Annual Conference And Offers Extensive "Hands-On" BoneScalpel™ and SonaStar® Product Demonstrations
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound...More >>
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound...More >>
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Galena Biopharma, Inc.
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Galena Biopharma, Inc.
Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the District of Oregon on behalf of purchasers (the "Class") of common stock of Galena Biopharma, Inc....More >>
Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the District of Oregon on behalf of purchasers (the "Class") of common stock of Galena Biopharma, Inc....More >>
Follow Your Gut: Preventing Colon Cancer Begins With Screening
Follow Your Gut: Preventing Colon Cancer Begins With Screening
Grandmother Sherry Jansma had never faced a serious health problem.More >>
Grandmother Sherry Jansma had never faced a serious health problem.More >>
Concise Analysis of the Electrophysiology Devices Market - Forecasts to 2019
Concise Analysis of the Electrophysiology Devices Market - Forecasts to 2019
Research and Markets (http://www.researchandmarkets.com/research/63p6kc/electrophysiology) has announced the addition of the "Concise Analysis of the Electrophysiology Devices Market - Forecasts to 2019" report to their...More >>
Research and Markets (http://www.researchandmarkets.com/research/63p6kc/electrophysiology) has announced the addition of the "Concise Analysis of the Electrophysiology Devices Market - Forecasts to 2019" report to their...More >>
Chiltern Wins CRO Leadership Award From Life Science Leader
Chiltern Wins CRO Leadership Award From Life Science Leader
Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity,...More >>
Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity,...More >>
OrthoSensor CEO Jay Pierce To Present At Canaccord Genuity Musculoskeletal Conference
OrthoSensor CEO Jay Pierce To Present At Canaccord Genuity Musculoskeletal Conference
OrthoSensor, Inc., the leader in Intelligent Orthopaedics and maker of the VERASENSE Knee System, announced today that its CEO and President Jay Pierce will present at the 2014 Canaccord Genuity Musculoskeletal Conference...More >>
OrthoSensor, Inc., the leader in Intelligent Orthopaedics and maker of the VERASENSE Knee System, announced today that its CEO and President Jay Pierce will present at the 2014 Canaccord Genuity Musculoskeletal Conference...More >>
Government regulations, enforcement, and compliance are chief issues to be addressed at the 2014 Compliance Institute
Government regulations, enforcement, and compliance are chief issues to be addressed at the 2014 Compliance Institute
Staying abreast of copious new and changing regulations brought about by health care reform, electronic health records, and social media is a chief goal of today's health care compliance professionals. The Health Care...More >>
Staying abreast of copious new and changing regulations brought about by health care reform, electronic health records, and social media is a chief goal of today's health care compliance professionals. The Health Care...More >>
Global Market Access Complexity Grows As The World's Biggest Pharma Markets React To Reforms And Emerging Markets Turn Their Attention To New Pricing Regulation
Global Market Access Complexity Grows As The World's Biggest Pharma Markets React To Reforms And Emerging Markets Turn Their Attention To New Pricing Regulation
Decision Resources Group finds that landmark healthcare legislation in developed markets across the globe, combined with evolving regulatory trends in emerging markets, has created a more complex global market access...More >>
Decision Resources Group finds that landmark healthcare legislation in developed markets across the globe, combined with evolving regulatory trends in emerging markets, has created a more complex global market access...More >>
Ocean Medical Center Opens New Emergency Department that Understands Patients Better
Ocean Medical Center Opens New Emergency Department that Understands Patients Better
Ocean Medical Center in Brick, NJ, has opened the new Hirair and Anna Hovnanian Emergency Care Center, which introduces a patient experience unlike any other in the region. The ribbon cutting to mark completion of the...More >>
Ocean Medical Center in Brick, NJ, has opened the new Hirair and Anna Hovnanian Emergency Care Center, which introduces a patient experience unlike any other in the region. The ribbon cutting to mark completion of the...More >>
Curemark CEO Joan Fallon To Speak At 2014 SXSW Interactive Festival
Curemark CEO Joan Fallon To Speak At 2014 SXSW Interactive Festival
Joan Fallon, founder and CEO of Curemark LLC, a research-driven biotechnology company focused on neurological disorders, will be a featured speaker at the SXSW Interactive Festival to be held March 7-11 in Austin, Texas.More >>
Joan Fallon, founder and CEO of Curemark LLC, a research-driven biotechnology company focused on neurological disorders, will be a featured speaker at the SXSW Interactive Festival to be held March 7-11 in Austin, Texas.More >>
Rubber Chemicals Market Update: A Biannual Report on Rubber Chemicals
Rubber Chemicals Market Update: A Biannual Report on Rubber Chemicals
Research and Markets ( http://www.researchandmarkets.com/research/vqvm7r/rubber_chemicals ) has announced the addition of the "Rubber Chemicals Market Update: A Biannual Report on Rubber Chemicals" report to their...More >>
Research and Markets ( http://www.researchandmarkets.com/research/vqvm7r/rubber_chemicals ) has announced the addition of the "Rubber Chemicals Market Update: A Biannual Report on Rubber Chemicals" report to their...More >>
Montee Law Firm Investigating Testosterone Injury Claims
Montee Law Firm Investigating Testosterone Injury Claims
The Montee Law Firm is a full-service personal injury law firm that has been protecting the rights of injured victims and families throughout Kansas City and the state of Missouri since 1996. Throughout the years, the...More >>
The Montee Law Firm is a full-service personal injury law firm that has been protecting the rights of injured victims and families throughout Kansas City and the state of Missouri since 1996. Throughout the years, the...More >>
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview
Research and Markets ( http://www.researchandmarkets.com/research/dgmfnn/omega3 ) has announced the addition of the "Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview" report to their offering. ...More >>
Research and Markets ( http://www.researchandmarkets.com/research/dgmfnn/omega3 ) has announced the addition of the "Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview" report to their offering. ...More >>
Clinical Decision Support System (CDSS) Market by Product, Model, Applications, Delivery Mode, Component - Global Forecast to 2018
Clinical Decision Support System (CDSS) Market by Product, Model, Applications, Delivery Mode, Component - Global Forecast to 2018
Dublin - Research and Markets (http://www.researchandmarkets.com/research/36rqth/clinical_decision) has announced the addition of the "Clinical Decision Support System (CDSS) Market by Product, Model, Applications,...More >>
Dublin - Research and Markets (http://www.researchandmarkets.com/research/36rqth/clinical_decision) has announced the addition of the "Clinical Decision Support System (CDSS) Market by Product, Model, Applications,...More >>
Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018
Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018
Research and Markets (http://www.researchandmarkets.com/research/8xcqhp/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global...More >>
Research and Markets (http://www.researchandmarkets.com/research/8xcqhp/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global...More >>
Cantel Medical Corp. to Present at the Sidoti & Company LLC 18th Annual Emerging Growth Institutional Investor Forum
Cantel Medical Corp. to Present at the Sidoti & Company LLC 18th Annual Emerging Growth Institutional Investor Forum
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Sidoti & Company, LLC 18th Annual Emerging Growth Institutional Investor Forum. The formal...More >>
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Sidoti & Company, LLC 18th Annual Emerging Growth Institutional Investor Forum. The formal...More >>
Sealantis Announces Successful Results of First Clinical Trial
Sealantis Announces Successful Results of First Clinical Trial
Sealantis Ltd. has announced positive results from its first clinical trial that tested the safety and performance of Seal-V, a vascular sealant that helps rapidly control bleeding during vascular surgery. The results...More >>
Sealantis Ltd. has announced positive results from its first clinical trial that tested the safety and performance of Seal-V, a vascular sealant that helps rapidly control bleeding during vascular surgery. The results...More >>
Families, Survivors and Clinicians Have a Chance to Show Solidarity in Support of Maternal Mental Health Care
Families, Survivors and Clinicians Have a Chance to Show Solidarity in Support of Maternal Mental Health Care
Maternal Mental Health disorders affect up to 20% of pregnant women and women in the postpartum period, and postpartum depression has been declared by the American Academy of Pediatrics as the most under-diagnosed...More >>
Maternal Mental Health disorders affect up to 20% of pregnant women and women in the postpartum period, and postpartum depression has been declared by the American Academy of Pediatrics as the most under-diagnosed...More >>
Patheon shareholders approve plan of arrangement
Patheon shareholders approve plan of arrangement
TORONTO, March 6, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI) ("Patheon") today announced that at a special meeting (the "Special Meeting") of holders of its restricted voting shares ("Shareholders") held earlier today,...More >>
TORONTO, March 6, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI) ("Patheon") today announced that at a special meeting (the "Special Meeting") of holders of its restricted voting shares ("Shareholders") held earlier today,...More >>
Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject
Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the presentation of data from its SB-728-T program to develop a 'functional cure' for HIV/AIDS at the Conference on Retroviruses and Opportunistic...More >>
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the presentation of data from its SB-728-T program to develop a 'functional cure' for HIV/AIDS at the Conference on Retroviruses and Opportunistic...More >>
Managed Health Services donates $1,000 to help save lives in heroin overdoses
Managed Health Services donates $1,000 to help save lives in heroin overdoses
Managed Health Services, one of the oldest Medicaid HMOs in Wisconsin, will donate $1,000 to the Racine County Sheriff's Department in support of a program to provide deputies with an antidote for heroin overdoses that...More >>
Managed Health Services, one of the oldest Medicaid HMOs in Wisconsin, will donate $1,000 to the Racine County Sheriff's Department in support of a program to provide deputies with an antidote for heroin overdoses that...More >>
BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMate™ for Glaucoma Surgery
BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMate™ for Glaucoma Surgery
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the...More >>
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the...More >>
PRA Recognized for Quality with Multiple CRO Leadership Awards
PRA Recognized for Quality with Multiple CRO Leadership Awards
PRA, a leading clinical research organization, today announced it has won two CRO Leadership Awards for quality. For its full-service offering, PRA received the "Quality in Emerging Biotech" award, while its Embedded...More >>
PRA, a leading clinical research organization, today announced it has won two CRO Leadership Awards for quality. For its full-service offering, PRA received the "Quality in Emerging Biotech" award, while its Embedded...More >>
Parents in the Dark
Parents in the Dark
As youth drug and alcohol abuse continues to grow, many parents say they are uninformed -- and largely unconcerned -- about the threat to their children.More >>
As youth drug and alcohol abuse continues to grow, many parents say they are uninformed -- and largely unconcerned -- about the threat to their children.More >>
N.J. Hospitals Provide Nearly $2.6 Billion in Community Benefits
N.J. Hospitals Provide Nearly $2.6 Billion in Community Benefits
New Jersey hospitals provided $2.58 billion in added benefits to their communities in 2012 above and beyond the healthcare services they provided to their patients, according to a new report from the New Jersey Hospital...More >>
New Jersey hospitals provided $2.58 billion in added benefits to their communities in 2012 above and beyond the healthcare services they provided to their patients, according to a new report from the New Jersey Hospital...More >>
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare
Today, Analysts Review released its analysts' notes regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), DENTSPLY International Inc. (NASDAQ: XRAY), AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), Cadence...More >>
Today, Analysts Review released its analysts' notes regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), DENTSPLY International Inc. (NASDAQ: XRAY), AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), Cadence...More >>
Concise Analysis of the International Shaving Lotions and Creams Market
Concise Analysis of the International Shaving Lotions and Creams Market
Research and Markets ( http://www.researchandmarkets.com/research/rppkv4/shaving_lotions ) has announced the addition of the "Concise Analysis of the International Shaving Lotions and Creams Market" report to their...More >>
Research and Markets ( http://www.researchandmarkets.com/research/rppkv4/shaving_lotions ) has announced the addition of the "Concise Analysis of the International Shaving Lotions and Creams Market" report to their...More >>
Lenox Hill HealthPlex to Debut This Summer in Greenwich Village
Lenox Hill HealthPlex to Debut This Summer in Greenwich Village
The North Shore-LIJ Health System today announced that its new comprehensive care center now under construction in Greenwich Village will be called "Lenox Hill HealthPlex." Located at 7th Avenue between W. 12th and 13th...More >>
The North Shore-LIJ Health System today announced that its new comprehensive care center now under construction in Greenwich Village will be called "Lenox Hill HealthPlex." Located at 7th Avenue between W. 12th and 13th...More >>
As Risperdal Gynecomastia Lawsuit Filings Continue, Bernstein Liebhard LLP Notes Publication of New Study Pertaining to Risperdal Side Effects
As Risperdal Gynecomastia Lawsuit Filings Continue, Bernstein Liebhard LLP Notes Publication of New Study Pertaining to Risperdal Side Effects
As Risperdal gynecomastia lawsuits (http://www.risperdallawsuitcenter.com/) continue to be filed on behalf of individuals who suffered gynecomastia (male breast growth) and other complications due to their use of the...More >>
As Risperdal gynecomastia lawsuits (http://www.risperdallawsuitcenter.com/) continue to be filed on behalf of individuals who suffered gynecomastia (male breast growth) and other complications due to their use of the...More >>
North American Healthcare Cloud Computing Market worth $6.5 Billion by 2018
North American Healthcare Cloud Computing Market worth $6.5 Billion by 2018
The report, "North America Healthcare Cloud Computing Market by Applications (EMR, PACS, RIS, RCM, APB), Deployment (Private, Public, Hybrid), Service (SAAS, IAAS), Pricing (Pay-As-You-Go, Spot) & End Users (Provider,...More >>
The report, "North America Healthcare Cloud Computing Market by Applications (EMR, PACS, RIS, RCM, APB), Deployment (Private, Public, Hybrid), Service (SAAS, IAAS), Pricing (Pay-As-You-Go, Spot) & End Users (Provider,...More >>
Concise Analysis of the Chinese Condom Industry
Concise Analysis of the Chinese Condom Industry
Research and Markets ( http://www.researchandmarkets.com/research/n8j7b9/research_report ) has announced the addition of the "Concise Analysis of the Chinese Condom Industry" report to their offering. ...More >>
Research and Markets ( http://www.researchandmarkets.com/research/n8j7b9/research_report ) has announced the addition of the "Concise Analysis of the Chinese Condom Industry" report to their offering. ...More >>
CPhI Pharma Insights: R&D Report
CPhI Pharma Insights: R&D Report
CPhI report shows R&D market diversifying innovation, with increased partnerships, mergers and revenue sharing models R&D sector to grow at over 8% driven by new evaluation techniques Report highlights: Increased...More >>
CPhI report shows R&D market diversifying innovation, with increased partnerships, mergers and revenue sharing models R&D sector to grow at over 8% driven by new evaluation techniques Report highlights: Increased...More >>
Concise Analysis of the International Vendor Neutral Archive & Picture Archiving and Communication System Market - Global Forecasts to 2018
Concise Analysis of the International Vendor Neutral Archive & Picture Archiving and Communication System Market - Global Forecasts to 2018
Dublin - Research and Markets (http://www.researchandmarkets.com/research/btxhhm/vendor_neutral) has announced the addition of the "Concise Analysis of the International Vendor Neutral Archive & Picture Archiving and...More >>
Dublin - Research and Markets (http://www.researchandmarkets.com/research/btxhhm/vendor_neutral) has announced the addition of the "Concise Analysis of the International Vendor Neutral Archive & Picture Archiving and...More >>
MedNet Solutions Welcomes Oncotherapeutics To The iMedNet Partner Program
MedNet Solutions Welcomes Oncotherapeutics To The iMedNet Partner Program
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Oncotherapeutics, a full service CRO with a unique focus on therapeutic oncology,...More >>
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Oncotherapeutics, a full service CRO with a unique focus on therapeutic oncology,...More >>
Surgery Center Network Partners With Third-Party Administrator Kempton Group
Surgery Center Network Partners With Third-Party Administrator Kempton Group
Surgery Center Network (SCN), the most comprehensive network of ambulatory surgery centers (ASCs) in the U.S., has announced a partnership with third-party administrator (TPA) The Kempton Group. As an SCN partner, The...More >>
Surgery Center Network (SCN), the most comprehensive network of ambulatory surgery centers (ASCs) in the U.S., has announced a partnership with third-party administrator (TPA) The Kempton Group. As an SCN partner, The...More >>
Vansen Pharma Inc. appoints Ali Moghaddam to its Board of Advisors
Vansen Pharma Inc. appoints Ali Moghaddam to its Board of Advisors
LAS VEGAS, March 6, 2014 /PRNewswire/ - Vansen Pharma Inc. [OTCQB: VNSN] is pleased to announce the appointment of Mr. Ali Moghaddam to its Board of Advisors. Mr. Moghaddam is an accomplished pharmaceutical executive with...More >>
LAS VEGAS, March 6, 2014 /PRNewswire/ - Vansen Pharma Inc. [OTCQB: VNSN] is pleased to announce the appointment of Mr. Ali Moghaddam to its Board of Advisors. Mr. Moghaddam is an accomplished pharmaceutical executive with...More >>
ANI Pharmaceuticals to Present at 26th Annual ROTH Conference
ANI Pharmaceuticals to Present at 26th Annual ROTH Conference
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that its President and Chief Executive Officer, Arthur S. Przybyl, is scheduled to present at the 26th Annual ROTH Conference at the Ritz-Carlton at Laguna Niguel,...More >>
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that its President and Chief Executive Officer, Arthur S. Przybyl, is scheduled to present at the 26th Annual ROTH Conference at the Ritz-Carlton at Laguna Niguel,...More >>
Pharmaceutical Membrane Filtration Market worth $7,960.3 Million by 2018
Pharmaceutical Membrane Filtration Market worth $7,960.3 Million by 2018
The report, "Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification,...More >>
The report, "Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification,...More >>
New Research Seeks To Prevent Preterm Birth With March Of Dimes Support
New Research Seeks To Prevent Preterm Birth With March Of Dimes Support
Five researchers seeking to understand the causes of premature birth with the goal of identifying women at risk of preterm labor and developing new treatments to prevent it have been awarded grant support from the March of...More >>
Five researchers seeking to understand the causes of premature birth with the goal of identifying women at risk of preterm labor and developing new treatments to prevent it have been awarded grant support from the March of...More >>
United Allergy Services Launches Mobile Healthcare App To Encourage Patient Medication Adherence
United Allergy Services Launches Mobile Healthcare App To Encourage Patient Medication Adherence
United Allergy Services (UAS), a leading healthcare services company that enables family physicians, pediatricians and health systems to deliver safe and effective allergy testing and customized immunotherapy services,...More >>
United Allergy Services (UAS), a leading healthcare services company that enables family physicians, pediatricians and health systems to deliver safe and effective allergy testing and customized immunotherapy services,...More >>
TNI BioTech, Inc. Forms New Subsidiary, Cytocom Inc., to develop LDN and MENK
TNI BioTech, Inc. Forms New Subsidiary, Cytocom Inc., to develop LDN and MENK
TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose Naltrexone (LDN) and Met-enkephalin (MENK).More >>
TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose Naltrexone (LDN) and Met-enkephalin (MENK).More >>
Valeant Pharmaceuticals Donates $250,000 To The National Coalition Against Domestic Violence
Valeant Pharmaceuticals Donates $250,000 To The National Coalition Against Domestic Violence
Valeant Pharmaceuticals North America, LLC, today announced it has donated $250,000 to the National Coalition Against Domestic Violence (NCADV). The donation is a reflection of Valeant's ongoing support and commitment...More >>
Valeant Pharmaceuticals North America, LLC, today announced it has donated $250,000 to the National Coalition Against Domestic Violence (NCADV). The donation is a reflection of Valeant's ongoing support and commitment...More >>
New England Biolabs® announces supply agreement with Lumora
New England Biolabs® announces supply agreement with Lumora
New England Biolabs, Inc. (NEB®), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing...More >>
New England Biolabs, Inc. (NEB®), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing...More >>
Concise Analysis of the International and China Monoclonal Antibody Industry
Concise Analysis of the International and China Monoclonal Antibody Industry
Research and Markets ( http://www.researchandmarkets.com/research/njgf7d/research_report ) has announced the addition of the "Concise Analysis of the International and China Monoclonal Antibody Industry" report to...More >>
Research and Markets ( http://www.researchandmarkets.com/research/njgf7d/research_report ) has announced the addition of the "Concise Analysis of the International and China Monoclonal Antibody Industry" report to...More >>
Veloxis Promotes John Weinberg to Chief Operating Officer
Veloxis Promotes John Weinberg to Chief Operating Officer
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that John Weinberg, M.D., currently chief commercial officer of Veloxis, has been promoted to chief operating officer.More >>
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that John Weinberg, M.D., currently chief commercial officer of Veloxis, has been promoted to chief operating officer.More >>
Concise Analysis of the International and Chinese Human Vaccine Industry
Concise Analysis of the International and Chinese Human Vaccine Industry
Research and Markets ( http://www.researchandmarkets.com/research/dwqqfq/research_report ) has announced the addition of the "Concise Analysis of the International and Chinese Human Vaccine Industry" report to their...More >>
Research and Markets ( http://www.researchandmarkets.com/research/dwqqfq/research_report ) has announced the addition of the "Concise Analysis of the International and Chinese Human Vaccine Industry" report to their...More >>
Concise Analysis of the International and Chinese In-Vitro Diagnostic Reagent Industry
Concise Analysis of the International and Chinese In-Vitro Diagnostic Reagent Industry
Research and Markets ( http://www.researchandmarkets.com/research/sc5st4/research_report ) has announced the addition of the "Concise Analysis of the International and Chinese In-Vitro Diagnostic Reagent Industry" ...More >>
Research and Markets ( http://www.researchandmarkets.com/research/sc5st4/research_report ) has announced the addition of the "Concise Analysis of the International and Chinese In-Vitro Diagnostic Reagent Industry" ...More >>
Zecotek files Two US Patents for 3D Display Technology
Zecotek files Two US Patents for 3D Display Technology
SINGAPORE, March 6, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has...More >>
SINGAPORE, March 6, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has...More >>
IAPAC, HIV Advocates, and AbbVie Issue Consensus Statement Calling for Improved Care for Women Living with HIV
IAPAC, HIV Advocates, and AbbVie Issue Consensus Statement Calling for Improved Care for Women Living with HIV
An international expert steering committee focused on women's issues released a consensus statement today to raise awareness of the need to improve care for women living with HIV. The consensus statement was developed...More >>
An international expert steering committee focused on women's issues released a consensus statement today to raise awareness of the need to improve care for women living with HIV. The consensus statement was developed...More >>
Concise Analysis of the International and China Blood Product Industry
Concise Analysis of the International and China Blood Product Industry
Research and Markets ( http://www.researchandmarkets.com/research/27pgqc/research_report ) has announced the addition of the "Concise Analysis of the International and China Blood Product Industry" report to their...More >>
Research and Markets ( http://www.researchandmarkets.com/research/27pgqc/research_report ) has announced the addition of the "Concise Analysis of the International and China Blood Product Industry" report to their...More >>
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta
Favorable Court Judgments, Stock Price Updates, and Upcoming Investors Conferences - Analyst Notes on Salix, Cerner, Hologic, Covance, and Synta
Today, Analysts Review released its analysts' notes regarding Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), Cerner Corporation (NASDAQ: CENR), Hologic Inc. (NASDAQ: HOLX), Covance Inc. (NYSE: CVD), and Synta...More >>
Today, Analysts Review released its analysts' notes regarding Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), Cerner Corporation (NASDAQ: CENR), Hologic Inc. (NASDAQ: HOLX), Covance Inc. (NYSE: CVD), and Synta...More >>
Amerinet Partners with BlueStep/BridgeGate Health to Provide EHR, Integration Services to Members
Amerinet Partners with BlueStep/BridgeGate Health to Provide EHR, Integration Services to Members
BlueStep/BridgeGate Health, provider of the LTPAC industry's only client-configurable care and clinical platform powered by high-performance data integration, today announced an agreement to deliver products and...More >>
BlueStep/BridgeGate Health, provider of the LTPAC industry's only client-configurable care and clinical platform powered by high-performance data integration, today announced an agreement to deliver products and...More >>
Jawbone Unveils New Data from Sleep Behavior Study, UP Features and Caffeine Tracker to Demonstrate the Impact of Sleep on Everyday Life
Jawbone Unveils New Data from Sleep Behavior Study, UP Features and Caffeine Tracker to Demonstrate the Impact of Sleep on Everyday Life
Jawbone® is today sharing findings from a comprehensive sleep behavior study based on data from the UP® system – the wristband, app and data service that helps you understand how you sleep, move and eat so you can make...More >>
Jawbone® is today sharing findings from a comprehensive sleep behavior study based on data from the UP® system – the wristband, app and data service that helps you understand how you sleep, move and eat so you can make...More >>
SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc.'s VAL-083 Clinical Trial
SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc.'s VAL-083 Clinical Trial
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar...More >>
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on DelMar...More >>
American Laser Skincare Launches Cutting-Edge Palomar Icon® and SilkPeel® Technology in Select Boston Locations
American Laser Skincare Launches Cutting-Edge Palomar Icon® and SilkPeel® Technology in Select Boston Locations
American Laser Skincare today announced that is has selected four Boston area clinics for a field test of two additions to its skin rejuvenation service portfolio. Peabody, Worcester, Braintree and Boston (Newbury Street)...More >>
American Laser Skincare today announced that is has selected four Boston area clinics for a field test of two additions to its skin rejuvenation service portfolio. Peabody, Worcester, Braintree and Boston (Newbury Street)...More >>
Polarion Secures $10 Million in Series A Funding from Siemens Venture Capital
Polarion Secures $10 Million in Series A Funding from Siemens Venture Capital
Siemens via its Venture Capital unit (SFS VC) has made a strategic corporate investment of $10 million (series A funding) in Polarion Software. The investment will allow Polarion to expand its product development...More >>
Siemens via its Venture Capital unit (SFS VC) has made a strategic corporate investment of $10 million (series A funding) in Polarion Software. The investment will allow Polarion to expand its product development...More >>
Deloitte Announced as Lead Sponsor for 10th Life Sciences Accounting & Reporting Congress
Deloitte Announced as Lead Sponsor for 10th Life Sciences Accounting & Reporting Congress
CBI is pleased to announce Deloitte as the lead sponsor for the 10th Life Sciences Accounting & Reporting Congress, which will be held March 17-19, 2014, at the Hyatt Regency Penn's Landing in Philadelphia. The...More >>
CBI is pleased to announce Deloitte as the lead sponsor for the 10th Life Sciences Accounting & Reporting Congress, which will be held March 17-19, 2014, at the Hyatt Regency Penn's Landing in Philadelphia. The...More >>
InspireMD to Present at the 26th Annual ROTH Conference
InspireMD to Present at the 26th Annual ROTH Conference
InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the 26th Annual ROTH Conference at the Ritz Carlton, Laguna Niguel in Dana Point, CA. The...More >>
InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), today announced that its CEO, Alan Milinazzo, will be presenting at the 26th Annual ROTH Conference at the Ritz Carlton, Laguna Niguel in Dana Point, CA. The...More >>
Varian Medical Systems to Exhibit Wireless Flat Panel Detectors, X-Ray Tubes for Digital Radiography and Image Processing Software at the European Congress of Radiology
Varian Medical Systems to Exhibit Wireless Flat Panel Detectors, X-Ray Tubes for Digital Radiography and Image Processing Software at the European Congress of Radiology
Expo C/Booth #316 – At this year's annual meeting of the European Congress of Radiology (ECR), Varian Medical Systems (NYSE:VAR) will exhibit a comprehensive line of imaging components to include digital X-ray image...More >>
Expo C/Booth #316 – At this year's annual meeting of the European Congress of Radiology (ECR), Varian Medical Systems (NYSE:VAR) will exhibit a comprehensive line of imaging components to include digital X-ray image...More >>
Oramed to Present at Upcoming Conferences
Oramed to Present at Upcoming Conferences
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the Company will present at the...More >>
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the Company will present at the...More >>
Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call
Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call
SEATTLE, March 6, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, March 13, 2014 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its full...More >>
SEATTLE, March 6, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, March 13, 2014 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its full...More >>
Immune Design Appoints William Ringo to Board of Directors
Immune Design Appoints William Ringo to Board of Directors
Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the appointment of biotechnology and pharmaceutical...More >>
Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced the appointment of biotechnology and pharmaceutical...More >>
MinuteClinic and Robert Wood Johnson University Hospital Agree to Clinical Collaboration in Central New Jersey
MinuteClinic and Robert Wood Johnson University Hospital Agree to Clinical Collaboration in Central New Jersey
MinuteClinic, the retail health care division of CVS Caremark (NYSE: CVS) and Robert Wood Johnson University Hospital (RWJ), one of the nation's leading academic medical centers, have signed a clinical collaboration to...More >>
MinuteClinic, the retail health care division of CVS Caremark (NYSE: CVS) and Robert Wood Johnson University Hospital (RWJ), one of the nation's leading academic medical centers, have signed a clinical collaboration to...More >>
Celsion Corporation to Hold Year-End 2013 Financial Results Conference Call on Thursday, March 13, 2014
Celsion Corporation to Hold Year-End 2013 Financial Results Conference Call on Thursday, March 13, 2014
Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss year-end 2013 financial results at 11:00 a.m. EST on Thursday, March 13, 2014. To participate in the call,...More >>
Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss year-end 2013 financial results at 11:00 a.m. EST on Thursday, March 13, 2014. To participate in the call,...More >>
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2013 Financial Results
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2013 Financial Results
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial results...More >>
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial results...More >>
Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer
Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer
Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today that Lorence Kim, M.D. will...More >>
Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics™, a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today that Lorence Kim, M.D. will...More >>
Global and Chinese Molybdenum Powder Industry Report 2014
Global and Chinese Molybdenum Powder Industry Report 2014
Research and Markets ( http://www.researchandmarkets.com/research/g9kpfz/global_and ) has announced the addition of the "Global and Chinese Molybdenum Powder Industry Report 2014" report to their offering. ...More >>
Research and Markets ( http://www.researchandmarkets.com/research/g9kpfz/global_and ) has announced the addition of the "Global and Chinese Molybdenum Powder Industry Report 2014" report to their offering. ...More >>
Maxwell Biotech Venture Fund's Portfolio Company Hepatera Completes Enrollment of Phase IIa clinical trial of Myrcludex B, for HBV
Maxwell Biotech Venture Fund's Portfolio Company Hepatera Completes Enrollment of Phase IIa clinical trial of Myrcludex B, for HBV
A group of 48 patients infected with the hepatitis B virus (HBV) have been enrolled in the phase IIa clinical trial of Myrcludex B by Russian biotech company Hepatera Ltd. Hepatera is financed by Maxwell Biotech Venture...More >>
A group of 48 patients infected with the hepatitis B virus (HBV) have been enrolled in the phase IIa clinical trial of Myrcludex B by Russian biotech company Hepatera Ltd. Hepatera is financed by Maxwell Biotech Venture...More >>
The CannaBusiness Group, Inc. acquires 17.3 Acres of Land with a Licensed California Medical Marijuana Cultivator Tenant
The CannaBusiness Group, Inc. acquires 17.3 Acres of Land with a Licensed California Medical Marijuana Cultivator Tenant
The CannaBusiness Group, Inc. (OTC: CBGI) Mission Viejo, Ca. March 6, 2014, acquires commercial property or land, they lease out the facilities for Agricultural, Industrial, Commercial and Retail, while managing the...More >>
The CannaBusiness Group, Inc. (OTC: CBGI) Mission Viejo, Ca. March 6, 2014, acquires commercial property or land, they lease out the facilities for Agricultural, Industrial, Commercial and Retail, while managing the...More >>
Ambulatory Surgical Facilities in Northeast Pennsylvania Collaborate with the Pennsylvania Patient Safety Authority to Reduce Day-of-Surgery (DOS) Cancellations
Ambulatory Surgical Facilities in Northeast Pennsylvania Collaborate with the Pennsylvania Patient Safety Authority to Reduce Day-of-Surgery (DOS) Cancellations
Ambulatory surgical facilities (ASFs) in northeast Pennsylvania collaborated with the Pennsylvania Patient Safety Authority and implemented protocols, like a nurse-driven preoperative screening and assessment, for reducing...More >>
Ambulatory surgical facilities (ASFs) in northeast Pennsylvania collaborated with the Pennsylvania Patient Safety Authority and implemented protocols, like a nurse-driven preoperative screening and assessment, for reducing...More >>
Concord Medical Announces Changes to the Board
Concord Medical Announces Changes to the Board
BEIJING, March 6, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest...More >>
BEIJING, March 6, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest...More >>
Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop Liver Cancer Drug
Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop Liver Cancer Drug
XIANYANG, China, March 6, 2014 /PRNewswire/-- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "corporation"), a China-based manufacturer and marketer of pharmaceutical and health supplement products for a...More >>
XIANYANG, China, March 6, 2014 /PRNewswire/-- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "corporation"), a China-based manufacturer and marketer of pharmaceutical and health supplement products for a...More >>
Catamaran Announces Proposed $500 Million Senior Notes Offering
Catamaran Announces Proposed $500 Million Senior Notes Offering
SCHAUMBURG, IL, March 6, 2014 /PRNewswire/ - Catamaran Corporation ("Catamaran") (NASDAQ: CTRX) (TSX: CCT), announced today that it has commenced an underwritten public offering of $500 million aggregate principal amount...More >>
SCHAUMBURG, IL, March 6, 2014 /PRNewswire/ - Catamaran Corporation ("Catamaran") (NASDAQ: CTRX) (TSX: CCT), announced today that it has commenced an underwritten public offering of $500 million aggregate principal amount...More >>
Healthcare 2020: Disrupt, Transform and Collapse
Healthcare 2020: Disrupt, Transform and Collapse
WHEN: 10:00 a.m. EST on Wednesday, March 19, 2014 LOCATION: Online, with free registration MODERATOR: Frost & Sullivan Partner and Senior Vice President of Healthcare and Life Sciences Reenita Das EXPERT PANELISTS:...More >>
WHEN: 10:00 a.m. EST on Wednesday, March 19, 2014 LOCATION: Online, with free registration MODERATOR: Frost & Sullivan Partner and Senior Vice President of Healthcare and Life Sciences Reenita Das EXPERT PANELISTS:...More >>
Echo Therapeutics to Exhibit at the ISICEM 2014 Critical Care Conference
Echo Therapeutics to Exhibit at the ISICEM 2014 Critical Care Conference
Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its clinical study...More >>
Echo Therapeutics, Inc. (Nasdaq: ECTE) ("Echo"), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, is pleased to announce that its clinical study...More >>
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch...More >>
Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch...More >>
Select Medical Corporation Announces Proposal to Commence an Offering of an Additional $110.0 Million of its 6.375% Senior Notes due 2021
Select Medical Corporation Announces Proposal to Commence an Offering of an Additional $110.0 Million of its 6.375% Senior Notes due 2021
Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") proposes to commence an offering through a private placement, subject to market and other conditions,...More >>
Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") proposes to commence an offering through a private placement, subject to market and other conditions,...More >>
Rigel Announces Publication of R118 AMPK Activator Research
Rigel Announces Publication of R118 AMPK Activator Research
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the American Journal of Physiology has published recent research results with its orally-bioavailable AMPK activator, R118. The publication, entitled...More >>
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the American Journal of Physiology has published recent research results with its orally-bioavailable AMPK activator, R118. The publication, entitled...More >>
Patheon Reports Preliminary Unaudited First Quarter Fiscal 2014 Results
Patheon Reports Preliminary Unaudited First Quarter Fiscal 2014 Results
TORONTO, March 6, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, with recently acquired proprietary products,...More >>
TORONTO, March 6, 2014 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, with recently acquired proprietary products,...More >>
Palatin Technologies To Present At The 26Th Annual ROTH Conference
Palatin Technologies To Present At The 26Th Annual ROTH Conference
Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 26th Annual ROTH Conference on Tuesday, March 11, 2014, at 3:30 p.m. Pacific Time. The conference will be held at the Ritz Carlton...More >>
Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 26th Annual ROTH Conference on Tuesday, March 11, 2014, at 3:30 p.m. Pacific Time. The conference will be held at the Ritz Carlton...More >>
Regado Biosciences to Provide Year-End and Fourth Quarter 2013 Financial Results
Regado Biosciences to Provide Year-End and Fourth Quarter 2013 Financial Results
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that it...More >>
Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that it...More >>
Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019
Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019
Research and Markets (http://www.researchandmarkets.com/research/hp66zf/organ) has announced the addition of the "Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast...More >>
Research and Markets (http://www.researchandmarkets.com/research/hp66zf/organ) has announced the addition of the "Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast...More >>
Elsevier Unveils New Digital Platform for Expert Consult, Student Consult
Elsevier Unveils New Digital Platform for Expert Consult, Student Consult
Clinicians and students will benefit from these medical reference and learning solutions enhanced by Inkling's feature-rich, intuitive and interactive digital platform Elsevier, a world-leading provider of scientific,...More >>
Clinicians and students will benefit from these medical reference and learning solutions enhanced by Inkling's feature-rich, intuitive and interactive digital platform Elsevier, a world-leading provider of scientific,...More >>
AMA CPT Editorial Panel Votes to Make MIS SI Joint Fusion a Category I Procedure
AMA CPT Editorial Panel Votes to Make MIS SI Joint Fusion a Category I Procedure
SI-BONE, Inc. (San Jose, California), a medical device company that has pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device used to fuse the sacroiliac (SI) joint, announced today...More >>
SI-BONE, Inc. (San Jose, California), a medical device company that has pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device used to fuse the sacroiliac (SI) joint, announced today...More >>
Omeros Reports Additional Positive Data from its OMS824 Phase 2a Schizophrenia Clinical Trial
Omeros Reports Additional Positive Data from its OMS824 Phase 2a Schizophrenia Clinical Trial
Omeros Corporation (NASDAQ: OMER) today announced additional positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor. Patients with schizophrenia were...More >>
Omeros Corporation (NASDAQ: OMER) today announced additional positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor. Patients with schizophrenia were...More >>

PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire

Medicine & Pharmaceuticals - Wandtv.com, NewsCenter17, StormCenter17, Central Illinois News-

Medicine & Pharmaceuticals News Releases via PRNewswireMore>>